John G. Gribben MD, DSc, FRCPath, FRCP, FMedSci

Professor John Gribben graduated in medicine from the University of Glasgow in 1980. He was a doctoral fellow at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School. He remained on the faculty for at Harvard Medical School 17 years before returning to the UK in 2005.

He specializes in hematological cancers including lymphomas, leukemias and bone marrow transplantation and immunotherapy approaches including CAR-T cells. He holds the Hamilton Fairley Chair of Medical Oncology at Barts and the London School of Medicine, Queen Mary, University of London and his NHS post is as Honorary Consultant Medical Oncologist Barts and The London NHS Trust. He is the author of more than 500 articles and chapters in peer-reviewed publications and has a global reputation for his work in researching new drugs and forms of cancer treatment and the tole of immunotherapy in cancer.